Canada markets open in 3 hours 12 minutes

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
8.400.00 (0.00%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 97.52M
Enterprise Value 72.55M
Trailing P/E 15.82
Forward P/E 17.86
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.24
Price/Book (mrq)2.81
Enterprise Value/Revenue 2.30
Enterprise Value/EBITDA 8.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.93
52-Week Change 39.09%
S&P500 52-Week Change 322.64%
52 Week High 39.26
52 Week Low 37.03
50-Day Moving Average 38.61
200-Day Moving Average 38.26

Share Statistics

Avg Vol (3 month) 36.19k
Avg Vol (10 day) 39.17k
Shares Outstanding 511.61M
Implied Shares Outstanding 611.74M
Float 89M
% Held by Insiders 138.45%
% Held by Institutions 11.37%
Shares Short (Apr 15, 2024) 41.72k
Short Ratio (Apr 15, 2024) 40.27
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.01%
Shares Short (prior month Mar 15, 2024) 41.25k

Dividends & Splits

Forward Annual Dividend Rate 40.18
Forward Annual Dividend Yield 42.14%
Trailing Annual Dividend Rate 30.16
Trailing Annual Dividend Yield 31.90%
5 Year Average Dividend Yield 4N/A
Payout Ratio 430.13%
Dividend Date 3Mar 15, 2024
Ex-Dividend Date 4Feb 28, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 20.45%
Operating Margin (ttm)18.48%

Management Effectiveness

Return on Assets (ttm)11.39%
Return on Equity (ttm)18.97%

Income Statement

Revenue (ttm)31.59M
Revenue Per Share (ttm)2.64
Quarterly Revenue Growth (yoy)10.90%
Gross Profit (ttm)N/A
EBITDA 7.76M
Net Income Avi to Common (ttm)6.46M
Diluted EPS (ttm)0.53
Quarterly Earnings Growth (yoy)20.90%

Balance Sheet

Total Cash (mrq)26.19M
Total Cash Per Share (mrq)2.26
Total Debt (mrq)1.22M
Total Debt/Equity (mrq)3.51%
Current Ratio (mrq)6.48
Book Value Per Share (mrq)2.96

Cash Flow Statement

Operating Cash Flow (ttm)5.05M
Levered Free Cash Flow (ttm)4.08M